Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Operating Leases (2017 - 2025)

Historic Operating Leases for Zepp Health (ZEPP) over the last 9 years, with Q3 2025 value amounting to $1.3 million.

  • Zepp Health's Operating Leases fell 4367.97% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 4367.97%. This contributed to the annual value of $2.0 million for FY2024, which is 3722.24% down from last year.
  • Latest data reveals that Zepp Health reported Operating Leases of $1.3 million as of Q3 2025, which was down 4367.97% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Zepp Health's Operating Leases ranged from a high of $82.7 million in Q3 2021 and a low of $1.1 million during Q2 2025
  • In the last 5 years, Zepp Health's Operating Leases had a median value of $11.1 million in 2021 and averaged $18.9 million.
  • As far as peak fluctuations go, Zepp Health's Operating Leases surged by 53102.19% in 2022, and later plummeted by 9227.44% in 2025.
  • Over the past 5 years, Zepp Health's Operating Leases (Quarter) stood at $11.1 million in 2021, then tumbled by 59.94% to $4.5 million in 2022, then decreased by 29.25% to $3.2 million in 2023, then tumbled by 36.33% to $2.0 million in 2024, then crashed by 35.18% to $1.3 million in 2025.
  • Its Operating Leases was $1.3 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.7 million in Q1 2025.